GB1247641A - 9alpha-FLUORO-16-FLUOROMETHYLENEPREDNISOLONE-21-ESTER AND PREPARATION THEREOF - Google Patents

9alpha-FLUORO-16-FLUOROMETHYLENEPREDNISOLONE-21-ESTER AND PREPARATION THEREOF

Info

Publication number
GB1247641A
GB1247641A GB2720/70A GB272070A GB1247641A GB 1247641 A GB1247641 A GB 1247641A GB 2720/70 A GB2720/70 A GB 2720/70A GB 272070 A GB272070 A GB 272070A GB 1247641 A GB1247641 A GB 1247641A
Authority
GB
United Kingdom
Prior art keywords
dione
reacting
fluoro
enanthate
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2720/70A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of GB1247641A publication Critical patent/GB1247641A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R4/00—Electrically-conductive connections between two or more conductive members in direct contact, i.e. touching one another; Means for effecting or maintaining such contact; Electrically-conductive connections having two or more spaced connecting locations for conductors and using contact members penetrating insulation
    • H01R4/02—Soldered or welded connections
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R9/00—Structural associations of a plurality of mutually-insulated electrical connecting elements, e.g. terminal strips or terminal blocks; Terminals or binding posts mounted upon a base or in a case; Bases therefor
    • H01R9/22—Bases, e.g. strip, block, panel
    • H01R9/28—Terminal boards

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB2720/70A 1969-02-11 1970-01-20 9alpha-FLUORO-16-FLUOROMETHYLENEPREDNISOLONE-21-ESTER AND PREPARATION THEREOF Expired GB1247641A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1906586A DE1906586C3 (de) 1969-02-11 1969-02-11 9 alpha-Fluor-16-fluormethylenprednisolon-21-önanthat, Verfahren zu seiner Herstellung und diese enthaltende pharmazeutische Zubereitung

Publications (1)

Publication Number Publication Date
GB1247641A true GB1247641A (en) 1971-09-29

Family

ID=5724819

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2720/70A Expired GB1247641A (en) 1969-02-11 1970-01-20 9alpha-FLUORO-16-FLUOROMETHYLENEPREDNISOLONE-21-ESTER AND PREPARATION THEREOF

Country Status (15)

Country Link
US (1) US3681409A (enExample)
AT (3) AT303277B (enExample)
BE (1) BE745708A (enExample)
BR (1) BR6915196D0 (enExample)
CH (1) CH534673A (enExample)
DE (1) DE1906586C3 (enExample)
DK (1) DK123475B (enExample)
ES (1) ES376409A1 (enExample)
FR (1) FR2034535B1 (enExample)
GB (1) GB1247641A (enExample)
HU (1) HU165223B (enExample)
IL (1) IL33812A (enExample)
NL (1) NL7001197A (enExample)
PL (1) PL80839B1 (enExample)
SE (1) SE356744B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572589B2 (en) 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
TW201914575A (zh) * 2017-09-19 2019-04-16 大江生醫股份有限公司 地龍蛋白用於製造調理皮膚醫藥組成物之用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH405306A (de) * 1959-02-10 1966-01-15 Ciba Geigy Verfahren zur Herstellung von Pregnadienverbindungen
DE1177151B (de) * 1961-06-08 1964-09-03 Merck Ag E Verfahren zur Herstellung von 16-Chlormethylen- bzw. 16-Brommethylen-steroiden

Also Published As

Publication number Publication date
AT298692B (de) 1972-05-25
CH534673A (de) 1973-03-15
BE745708A (enExample) 1970-08-10
DE1906586B2 (de) 1973-06-07
DK123475B (da) 1972-06-26
IL33812A0 (en) 1970-03-22
AT305503B (de) 1973-01-15
NL7001197A (enExample) 1970-08-13
AT303277B (de) 1972-10-15
FR2034535B1 (enExample) 1973-01-12
HU165223B (enExample) 1974-07-27
IL33812A (en) 1973-05-31
ES376409A1 (es) 1973-01-01
DE1906586C3 (de) 1974-01-03
FR2034535A1 (enExample) 1970-12-11
BR6915196D0 (pt) 1973-02-13
PL80839B1 (enExample) 1975-08-30
DE1906586A1 (de) 1970-11-05
US3681409A (en) 1972-08-01
SE356744B (enExample) 1973-06-04

Similar Documents

Publication Publication Date Title
CA1134345A (en) Thio etianic acid derivatives
JPS6040439B2 (ja) ヒドロコルチゾン誘導体
KR950005838A (ko) 코티코스테로이드 17- 알킬 카보네이트21-[0]-카복실산 및 카본산 에스테르, 이들의 제조방법 및 이들 화합물을 함유하는 약제
US3383394A (en) Novel 17-acylating process and products thereof
US2865935A (en) 2-methyl steroids and process
JPS6043358B2 (ja) 9α−ハロ−18−メチル−21−デスオキシプレドニンロンのエステル類の製造法
GB1141335A (en) í¸-pregnadiene compounds and their preparation
US2966486A (en) 16alpha, 17alpha-substituted methylene dioxy ethers of steroids of the pregnane series and method of preparing the same
GB928302A (en) í¸-pregnene compounds
US3385872A (en) Process for the preparation of 3-hydroxy-19-nor-delta1, 3, 5(10), 9(11)-tetraene steroids
US3163664A (en) 21-hemi-alpha, beta-dialkylsuccinates of corticoids
US2953581A (en) 3-oxygenated-20-keto-21-fluoro-pregnanes
IE35822L (en) 6ó, 16ó-dimethylsteroids.
GB892620A (en) Cyclopentanophenanthrene derivatives
CH625254A5 (enExample)
JPS6150960B2 (enExample)
IE32397L (en) Halogenated steroids
US3546261A (en) Novel ethoxylated acetic acid esters of pregnane-21-ols
US3118880A (en) 9alpha-halo-11-hydroxy testosterone and intermediates in the production thereof
GB994743A (en) Cyclopentanophenanthrene compounds and process for their production
IE34816L (en) 15ß, 16ß-METHYLENE STEROIDS.
GB1223087A (en) Improvements in or relating to new steroid 21-esters, method for their preparation and therapeutic composition containing same
GB1064078A (en) 5-a-pregnano-[3,2-c]pyrazole compounds
GB836974A (en) Improvements in or relating to steroids and the manufacture thereof
GB1367928A (en) Halogenopregnadiene and process for its manufacture